Coding mutations in p57(KIP2) are present in some cases of Beckwith- Wiedemann syndrome but are rare or absent in Wilms tumors

American Journal of Human Genetics

Volumn 61, Issue 2, 1997, Pages 295-303

  O'Keefe, Denise ^a   Dao, Diem ^a   Zhao, Long ^a   Sanderson, Rhonda ^b   Warburton, Dorothy ^a   Weiss, Lawrence ^c   Anyane Yeboa, Kwame ^a   Tycko, Benjamin ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b OVERLOOK HOSPITAL   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; RIBONUCLEASE; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; ENZYME INHIBITOR; MUSCLE PROTEIN; NUCLEAR PROTEIN; RNA H19; UNTRANSLATED RNA;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER SUSCEPTIBILITY; CHROMOSOME 11P; CLINICAL ARTICLE; EXON; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GLOSSECTOMY; HETEROZYGOSITY LOSS; HUMAN; INTRON; NEPHROBLASTOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; CELL CULTURE; CHROMOSOME 11; DNA METHYLATION; DRUG ANTAGONISM; ENZYMOLOGY; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; GENOME IMPRINTING; INFANT; KIDNEY TUMOR; MALE; MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; TUMOR SUPPRESSOR GENE;

BECKWITH-WIEDEMANN SYNDROME; CELLS, CULTURED; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; ENZYME INHIBITORS; FEMALE; GENES, WILMS TUMOR; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; GERM-LINE MUTATION; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MUSCLE PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, UNTRANSLATED; SEQUENCE DELETION; WILMS TUMOR;

EID: 0030610260     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/514854     Document Type: Article

References (30)

1. Chung W-Y, Yuan L, Feng L, Hensle T, Tycko B (1996) Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Mol Genet 8:1101-1108
2. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993) Tumour-suppressor activity of H19 RNA. Nature 365:764-767
3. Hatada I, Inazawa J, Abe T, Nakayama M, Yasuhiko K, Jinno Y, Niikawa N, et al (1996a) Genomic imprinting of human pS7KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5:783-788
4. Hatada I, Mukai T (1995) Genomic imprinting of p57Kip2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11:204-206
5. Hatada I, Ohashi H, Fukushima Y, Kaneko Y, Inoue M, Komoto Y, Okada A, et al (1996b) An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 13:171-173
6. Henry I, Bonaïti-Pellié C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991) Uniparental disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667
7. Henry I, Puech A, Riesewijk A, Ahnine L, Mannens M, Beldjord C, Bitoun P, et al (1993) Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome: a post-fertilization event. Eur J Hum Genet 1:19-29
8. Hoovers JMN, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, et al (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 92: 12456-12460
9. Junien C (1992) Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Dev 2:431-438
10. Kondo M, Matsuoka S, Uchida K, Osada H, Nagatake M, Takagi K, Harper JW, et al (1996) Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene 12:1365-1368
11. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, et al (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719
12. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiatis A, Tilghman SM (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39
13. Mannens M, Hoovers JM, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, et al (1994) Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet 2:3-23
14. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, et al (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662
15. Matsuoka S, Thompson JS, Edwards MC, Barletta JM, Grundy P, Kalikin LM, Harper JW, et al (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.5. Proc Natl Acad Sci USA 93:3026-3030
16. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE (1996) Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med 2:311-316
17. Moulton T, Chung W-Y, Yuan L, Hensle T, Waber P, Nisen P, Tycko B (1996) Genomic imprinting and Wilms' tumor. Med Pediatr Oncol 27:476-483
18. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, et al (1994) Epigenetic lesions at the H19 locus in Wilms' tumor patients. Nat Genet 7:440-447
19. Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee M-H, Gerald WL, et al (1996) Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Res 56:1219-1221
20. Overall ML, Spencer J, Bakker M, Dziadek M, Smith PJ (1996) . p57KIP2 is expressed in Wilms' tumor with LOH of 11p15.5. Genes Chromosom Cancer 17:56-59
21. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720-723
22. Rainier S, Johnson L, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747-749
23. Reik W, Brown KW, Schneid H, Le Bouc Y, Bickmore W, Maher ER (1995) Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet 4:2379-2385
24. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structure of the p27KIP1 cyclin-dependent-kinase inhibitor bound to the cyclinA-cdk2 complex. Nature 382:325-331
25. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat Genet 7:433-439
26. Taniguchi T, Sullivan MJ, Osamu O, Reeve A (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 92: 2159-2163
27. Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y (1996) Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 97:625-631
28. Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung W-Y, Tang M-X, et al (1996) Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum Genet 98: 430-436
29. Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet 5:143-150
30. Weksberg R, Squire JA (1996) Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol 27:462-469